Enanta Pharma (ENTA) Tops Q1 EPS by 17c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($1.39), $0.17 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $21.85 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• Ciena beats estimates on strong AI-driven demand, shares rise
• Momo (MOMO) Tops Q2 EPS by 8c; offers guidance
• John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance